Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moschos

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Nature Medicine|April 27, 2023
Multi-organ landscape of therapy-resistant melanomaSixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, et al.
Plos One|August 23, 2012
Mitochondrial respiration--an important therapeutic target in melanomaMichelle Barbi de Moura, Garret Vincent, Shelley L Fayewicz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanomaStergios J Moschos, Cindy A Sander, Wenjun Wang, et al.
JCO Precision Oncology|July 17, 2018
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of <i>POLD1</i> and <i>MLH1</i>Manish R Sharma, James T Auman, Nirali M Patel, et al.
The Journal of Clinical Investigation|April 9, 2013
HIF1α and HIF2α independently activate SRC to promote melanoma metastasesSara C Hanna, Bhavani Krishnan, Sean T Bailey, et al.
The American Journal of Surgical Pathology|January 13, 2026
Prognostic Value of a Novel Nuclear Grading of Cutaneous Melanoma: The UNC Chapel Hill MethodSarah G McAlpine, Shantanu Srivatsa, Paige C Jones, et al.
The Lancet. Oncology|June 9, 2017
Dabrafenib plus trametinib in patients with BRAF<sup>V600</sup>-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trialMichael A Davies, Philippe Saiag, Caroline Robert, et al.
Breast Cancer Research and Treatment|April 25, 2019
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastasesMaria J Sambade, Grace Prince, Allison M Deal, et al.
Frontiers in Oncology|February 8, 2021
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain MetastasesDimitri G Trembath, Eric S Davis, Shanti Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204Raymond Y Huang, Gilbert Youssef, Thomas Nelson, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Nature Medicine|April 27, 2023
Multi-organ landscape of therapy-resistant melanomaSixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, et al.
Plos One|August 23, 2012
Mitochondrial respiration--an important therapeutic target in melanomaMichelle Barbi de Moura, Garret Vincent, Shelley L Fayewicz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanomaStergios J Moschos, Cindy A Sander, Wenjun Wang, et al.
JCO Precision Oncology|July 17, 2018
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of <i>POLD1</i> and <i>MLH1</i>Manish R Sharma, James T Auman, Nirali M Patel, et al.
The Journal of Clinical Investigation|April 9, 2013
HIF1α and HIF2α independently activate SRC to promote melanoma metastasesSara C Hanna, Bhavani Krishnan, Sean T Bailey, et al.
The American Journal of Surgical Pathology|January 13, 2026
Prognostic Value of a Novel Nuclear Grading of Cutaneous Melanoma: The UNC Chapel Hill MethodSarah G McAlpine, Shantanu Srivatsa, Paige C Jones, et al.
The Lancet. Oncology|June 9, 2017
Dabrafenib plus trametinib in patients with BRAF<sup>V600</sup>-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trialMichael A Davies, Philippe Saiag, Caroline Robert, et al.
Breast Cancer Research and Treatment|April 25, 2019
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastasesMaria J Sambade, Grace Prince, Allison M Deal, et al.
Frontiers in Oncology|February 8, 2021
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain MetastasesDimitri G Trembath, Eric S Davis, Shanti Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204Raymond Y Huang, Gilbert Youssef, Thomas Nelson, et al.
Pageof 9